Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?

por Smit, M. D., Van Gelder, I. C.
Publicado 2011

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation

por Deuling, J. H. H., Vermeulen, R. P., Smit, M. D., van der Maaten, J. M. A. A., Boersema, H. M., van den Heuvel, A. F. M., Van Gelder, I. C.
Publicado 2011

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study

por Alings, M., Smit, M. D., Moes, M. L., Crijns, H. J. G. M., Tijssen, J. G. P., Brügemann, J., Hillege, H. L., Lane, D. A., Lip, G. Y. H., Smeets, J. R. L. M., Tieleman, R. G., Tukkie, R., Willems, F. F., Vermond, R. A., Van Veldhuisen, D. J., Van Gelder, I. C.
Publicado 2013